Why Evertec Inc (NYSE:EVTC) Stock went down -12.71% in Last Year?
Susquehanna lowered the price target for the Evertec Inc (NYSE:EVTC) stock from “a Positive” to “a Neutral”. The rating was released on January 24, 2022, according to finviz. The research report from Goldman has initiated the stock to Neutral, with a price target set at $29. The stock was initiated by Susquehanna, who disclosed in […]
Integral Ad Science Holding Corp (NASDAQ:IAS) Stock is trading Lower -9.50% From 200-Day SMA
Loop Capital raised the price target for the Integral Ad Science Holding Corp (NASDAQ:IAS) stock to “a Buy”. The rating was released on April 30, 2024, according to finviz. We previously noted in another research note published on April 16, 2024 by Morgan Stanley that downgraded the stock from an Overweight to an Equal-weight with […]
Analysts Rating: Pan American Silver Corp (NYSE:PAAS) Stock Won “a Hold” Rating From Jefferies
Jefferies raised the price target for the Pan American Silver Corp (NYSE:PAAS) stock to “a Hold”. The rating was released on February 29, 2024, according to finviz. The research report from RBC Capital Mkts has upgraded the stock from Sector Perform to Outperform, with a price target set at $22. The stock was upgraded by […]
Cellebrite DI Ltd (NASDAQ:CLBT) stock Posted Operating Margin of 12.27 percent in Last Year: Is Admissible?
Needham raised the price target for the Cellebrite DI Ltd (NASDAQ:CLBT) stock to “a Buy”. The rating was released on March 28, 2024, according to finviz. The research report from BofA Securities has upgraded the stock from Neutral to Buy, with a price target set at $12. The stock was initiated by Craig Hallum, who […]
Why Dynavax Technologies Corp. (NASDAQ:DVAX) Stock up 4.02% in Last Week?
Goldman raised the price target for the Dynavax Technologies Corp. (NASDAQ:DVAX) stock to “a Neutral”. The rating was released on February 01, 2024, according to finviz. The research report from Goldman has resumed the stock to Buy, with a price target set at $38. The stock was initiated by Goldman, who disclosed in a research […]
Collegium Pharmaceutical Inc (NASDAQ:COLL) stock Reported Profit Margin of 16.46 percent in Last Year: Is Defensible?
H.C. Wainwright raised the price target for the Collegium Pharmaceutical Inc (NASDAQ:COLL) stock from “a Neutral” to “a Buy”. The rating was released on Jul-31-24, according to finviz. We previously noted in another research note published on June 07, 2024 by Jefferies that upgraded the stock from a Hold to a Buy with a price […]
Wolfe Research Assigned “an Outperform” Rating to Valero Energy Corp. (NYSE:VLO) Stock
Wolfe Research raised the price target for the Valero Energy Corp. (NYSE:VLO) stock to “an Outperform”. The rating was released on July 18, 2024, according to finviz. We previously noted in another research note published on July 17, 2024 by Mizuho that upgraded the stock from a Neutral to an Outperform with a price target […]
AZEK Company Inc (NYSE:AZEK) stock is trading 81.02 percent above its 52-week low
BMO Capital Markets lowered the price target for the AZEK Company Inc (NYSE:AZEK) stock from “an Outperform” to “a Market perform”. The rating was released on July 23, 2024, according to finviz. We previously noted in another research note published on July 03, 2024 by DA Davidson that downgraded the stock from a Buy to […]
YETI Holdings Inc (NYSE:YETI) Stock is trading Above 2.39% From 50-Day SMA
Canaccord Genuity raised the price target for the YETI Holdings Inc (NYSE:YETI) stock from “a Buy” to “a Hold”. The rating was released on January 04, 2024, according to finviz. The research report from Morgan Stanley has resumed the stock to Equal-Weight, with a price target set at $50. The stock was initiated by B. […]
Alkermes plc (NASDAQ:ALKS) Stock lower -0.40% in This Year: What’s Happened?
TD Cowen raised the price target for the Alkermes plc (NASDAQ:ALKS) stock to “a Buy”. The rating was released on June 17, 2024, according to finviz. The research report from UBS has downgraded the stock from Neutral to Sell, with a price target set at $25. The stock was resumed by JP Morgan, who disclosed […]
